In vitro investigation of self-assembled nanoparticles based on hyaluronic acid-deoxycholic acid conjugates for controlled release doxorubicin: effect of degree of substitution of deoxycholic acid. [PDF]
Wei WH, Dong XM, Liu CG.
europepmc +1 more source
Laquinimod treatment in the R6/2 mouse model. [PDF]
Ellrichmann G +10 more
europepmc +1 more source
Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease. [PDF]
Siew JJ +11 more
europepmc +1 more source
Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. [PDF]
Banerjee R, Beal MF, Thomas B.
europepmc +1 more source
Virology, immunology and pathology of human rabies during treatment. [PDF]
Caicedo Y +9 more
europepmc +1 more source
Bepaling percentage aal onder de totaal-TEQ limiet in de voor aalvangst gesloten gebieden [PDF]
In de voor aalvangst gesloten gebieden is het gemiddelde gehalte van totaal-TEQ (ToxicEQuivalents; een maat voor de dioxine-achtige toxiciteit) in aal, gemeten in de jaarlijkse monitoring, normoverschrijdend. Op basis hiervan heeft de Staatsecretaris van
Bierman, S.M. +4 more
core +2 more sources
Molecular Analysis and Bioinformatics Assessment of Full-Length L1 Gene of Bovine Papillomavirus Type-1 as a Potential DNA Vaccine Study. [PDF]
Abdul-Zahra HH +2 more
europepmc +1 more source
The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington's disease. [PDF]
Farina F +10 more
europepmc +1 more source
Prevalence and risk factors of pre-frailty and frailty in hemodialysis patients in central China. [PDF]
Jiang S +8 more
europepmc +1 more source
Safety of TeaCrine®, a non-habituating, naturally-occurring purine alkaloid over eight weeks of continuous use. [PDF]
Taylor L +6 more
europepmc +1 more source

